Skip to main content

Table 1 demographic and clinical features of study subjects

From: The effect of glatiramer acetate, IFNβ-1a, fingolimod, and dimethyl fumarate on the expression of T-bet, IFN-γ, and MEG3 in PBMC of RRMS patients

Demographic features

Patients (n = 52)

Controls (n = 20)

Gender

Male n (%)

female n (%)

13 (25%)

39 (75%)

6 (30%)

14 (70%)

Age (year)

at time of analysis, median (range)

at onset, median (range)

Disease duration, median (range)

29 (17–67)

24.5 (11–63)

6 (0.1–23)

26 (18–49)

EDSS score, median (range)

3 (1–8)

 

1–4 (%)

32 (62)

 

4–7 (%)

17 (31)

 

7\(\le\) (%)

3 (7)